The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of TTI-621, a novel immune checkpoint inhibitor targeting CD47, in subjects with relapsed or refractory hematologic malignancies.
 
Stephen Maxted Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Bristol-Myers Squibb (Inst); Celldex (Inst); Seagen (Inst)
 
Robert W. Chen
Honoraria - Seagen
Consulting or Advisory Role - Genentech; Merck; Millennium; Seagen
Speakers' Bureau - Genentech; Millennium; Seagen
Research Funding - Merck (Inst); Millennium (Inst); Seagen (Inst)
 
Ian Flinn
Stock and Other Ownership Interests - RainTree Oncology Services
Research Funding - Acerta Pharma (Inst); Agios (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunogen (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Michael B. Maris
No Relationships to Disclose
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals
 
Elizabeth Wieland
Employment - Trillium Therapeutics
Stock and Other Ownership Interests - Trillium Therapeutics
Consulting or Advisory Role - Loxo; Trillium Therapeutics
Travel, Accommodations, Expenses - Loxo; Trillium Therapeutics
 
Eric L. Sievers
Employment - Seagen; Trillium Therapeutics
Stock and Other Ownership Interests - Seagen; Trillium Therapeutics
Consulting or Advisory Role - MEI Pharma